“Kazia how to raise funds without entering into a death spiral arrangement? You do realise, I hope, that the going rate in the US for nano-companies with low liquidity and slow news flow is a 20-25% discount + 100% warrant coverage + fees + broker warrants?imo”
Borrowed from a wise poster with great knowledge on biotechs imo
imo
Reality is that trials need significant capital - imo why market cap is where it is no matter how many trials have commenced
KZA Media Thread, page-133
-
- There are more pages in this discussion • 1,934 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)